NCT05252728View on ClinicalTrials.gov

Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D

CompletedOBSERVATIONAL
Enrollment

372

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Type 1 Diabetes Mellitus Maturity Onset
Trial Locations (1)

410011

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Second Xiangya Hospital of Central South University

OTHER

NCT05252728 - Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D | Biotech Hunter | Biotech Hunter